Portable PCR Opportunity Ahram offers portable high-speed PCR devices (Palm PCR) with multiple iterations including economy models. Potential upsell of higher throughput kits, ruggedized versions, and service plans to expand field deployment across research labs, clinical partners, and on-site testing providers.

Cell Assay Demand In addition to PCR, the company develops cell-based assay systems for life science and pharmaceutical research. Target opportunities include contract research organizations, biopharma collaborations, and academic labs seeking integrated workflows combining rapid PCR with cell-based readouts.

Global Footprint Headquartered in Seoul with a Silicon Valley office suggests readiness for international sales and North American partnerships. Focus sales efforts on cross-border distribution, regional regulatory support, and local service presence to accelerate adoption in both Asia and the U.S.

Patented Tech Edge Ahram holds numerous PCR and cell-based assay patents, signaling a defensible tech position. Leverage IP as a differentiator in proposals, pursue licensing inquiries, and propose joint ventures with research institutions seeking access to protected, unique capabilities.

Growth Through Ecosystems Historical product launches of Palm PCR variants and ASF Fast POCT System indicate a pattern of expanding tool ecosystems for rapid diagnostics and field testing. Identify collaborators and distributors in veterinary, agricultural, and public health sectors to broaden market reach with complementary product bundles.